Catalyst Pharmaceutical CPRX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's change in lease liabilities?
- Catalyst Pharmaceutical (CPRX) reported change in lease liabilities of -$106K in Q1 2026.
- How has Catalyst Pharmaceutical's change in lease liabilities changed year-over-year?
- Catalyst Pharmaceutical's change in lease liabilities decreased by 9.3% year-over-year, from -$97K to -$106K.
- What is the long-term trend for Catalyst Pharmaceutical's change in lease liabilities?
- Over 3 years (2022 to 2025), Catalyst Pharmaceutical's change in lease liabilities has grown at a 9.3% compound annual growth rate (CAGR), from -$307K to -$401K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.